Xenon Pharmaceuticals Inc.
NASDAQ:XENE · NASDAQ Global Market
-$0.29 today
Vol 1.90M · Avg 1.16M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+68.02%
Period High
$62.76
Period Low
$30.30
Latest
$52.91
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Centessa Pharmaceuticals plc
NASDAQ:CNTA
$6.16B
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.64B
Apogee Therapeutics, Inc.
NASDAQ:APGE
$5.44B
Legend Biotech Corporation
NASDAQ:LEGN
$5.44B
CG Oncology, Inc. Common stock
NASDAQ:CGON
$5.38B
Travere Therapeutics, Inc.
NASDAQ:TVTX
$5.06B
Celcuity Inc.
NASDAQ:CELC
$4.07B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.69B
Zai Lab Limited
NASDAQ:ZLAB
$2.09B
Ascentage Pharma Group International
NASDAQ:AAPG
$403.00M
What is the latest XENE filing?
The latest filing shown is 4 dated Jun 8, 2026.
How many recent filings does XENE have?
Intrinsic Alpha currently shows 20 recent filings for XENE.
Explore More
Continue the stock analysis
Jump to another research area for this company.